Joseph H. Porter - Publications

Affiliations: 
Virginia Commonwealth University, Richmond, VA, United States 
Area:
Behavioral Pharmacology of Antipsychotics Drugs, Leraning & Cognition

91 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Hillhouse TM, Partridge KJ, Garrett PI, Honeycutt SC, Porter JH. Effects of (2R,6R)-hydroxynorketamine in assays of acute pain-stimulated and pain-depressed behaviors in mice. Plos One. 19: e0301848. PMID 38640139 DOI: 10.1371/journal.pone.0301848  0.656
2023 Donahue TJ, Hillhouse TM, Webster KA, Young R, De Oliveira EO, Porter JH. Examination of the mechanisms underlying the discriminative stimulus properties of the atypical antipsychotic amisulpride. Behavioural Pharmacology. 35: 47-54. PMID 38375659 DOI: 10.1097/FBP.0000000000000760  0.84
2023 Mustafa MA, Poklis JL, Karin KN, Elmer JA, Porter JH, Parra V, Lu D, Schlosburg JE, Lichtman AH. Investigation of Cannabidiol in the Mouse Drug Discrimination Paradigm. Cannabis and Cannabinoid Research. PMID 36656312 DOI: 10.1089/can.2022.0198  0.589
2022 van den Berg M, Magaraggia I, Schreiber R, Hillhouse TM, Porter JH. How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework. Psychopharmacology. PMID 35348806 DOI: 10.1007/s00213-022-06106-8  0.69
2021 Peterson ML, Clark CT, Lynch CJ, Cooper JT, Gelfman N, Blumenstein J, Hansen R, Porter JH, Hillhouse TM. Preliminary assessment of the subjective effects of electronic-cigarettes in young-adult low-dose electronic-cigarette users: Effects of nicotine dose and e-liquid flavor. Journal of American College Health : J of Ach. 1-10. PMID 34283707 DOI: 10.1080/07448481.2021.1950162  0.682
2021 Zhang F, Hillhouse TM, Anderson PM, Koppenhaver PO, Kegen TN, Manicka SG, Lane JT, Pottanat E, Van Fossen M, Rice R, Porter JH. Opioid receptor system contributes to the acute and sustained antidepressant-like effects, but not the hyperactivity motor effects of ketamine in mice. Pharmacology, Biochemistry, and Behavior. 173228. PMID 34224734 DOI: 10.1016/j.pbb.2021.173228  0.746
2019 Hillhouse TM, Rice R, Porter JH. What role does the (2R,6R)-hydronorketamine metabolite play in the antidepressant-like and abuse-related effects of (R)-ketamine? British Journal of Pharmacology. PMID 31288299 DOI: 10.1111/Bph.14785  0.67
2019 Donahue TJ, Webster KA, Hillhouse TM, De Oliveira EO, Porter JH. Discriminative stimulus properties of the typical antipsychotic haloperidol compared to other antipsychotic drugs in C57BL/6 mice. Behavioural Pharmacology. PMID 31058657 DOI: 10.1097/Fbp.0000000000000487  0.851
2018 Hillhouse TM, Merritt CR, Smith DA, Cajina M, Sanchez C, Porter JH, Pehrson AL. Vortioxetine Differentially Modulates MK-801-Induced Changes in Visual Signal Detection Task Performance and Locomotor Activity. Frontiers in Pharmacology. 9: 1024. PMID 30271344 DOI: 10.3389/Fphar.2018.01024  0.787
2018 Porter JH, Prus AJ, Overton DA. Drug Discrimination: Historical Origins, Important Concepts, and Principles. Current Topics in Behavioral Neurosciences. PMID 29637526 DOI: 10.1007/7854_2018_40  0.834
2018 Manvich DF, Webster KA, Foster SL, Farrell MS, Ritchie JC, Porter JH, Weinshenker D. The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice. Scientific Reports. 8: 3840. PMID 29497149 DOI: 10.1038/S41598-018-22116-Z  0.702
2017 Donahue TJ, Hillhouse TM, Webster KA, Young R, De Oliveira EO, Porter JH. Discriminative stimulus properties of the atypical antipsychotic amisulpride: comparison to its isomers and to other benzamide derivatives, antipsychotic, antidepressant, and antianxiety drugs in C57BL/6 mice. Psychopharmacology. PMID 28921163 DOI: 10.1007/S00213-017-4738-Y  0.839
2017 Porter JH, Webster KA, Prus AJ. Translational Value of Drug Discrimination with Typical and Atypical Antipsychotic Drugs. Current Topics in Behavioral Neurosciences. PMID 28341945 DOI: 10.1007/7854_2017_4  0.866
2017 Porter JH, Manvich DF, Webster KA, Foster SL, Farrell MS, Weinshenker D. Behavioral and Pharmacokinetic Properties of the Putatively-Inert DREADD Ligand Clozapine-N-Oxide (CNO) in Rats and Mice The Faseb Journal. 31. DOI: 10.1096/Fasebj.31.1_Supplement.Lb594  0.658
2016 Prus AJ, Wise LE, Pehrson AL, Philibin SD, Bang-Andersen B, Arnt J, Porter JH. Discriminative stimulus properties of 1.25 mg/kg clozapine in rats: mediation by serotonin 5-HT2and dopamine D4 receptors. Brain Research. PMID 27502027 DOI: 10.1016/J.Brainres.2016.08.004  0.841
2016 Pehrson AL, Hillhouse TM, Haddjeri N, Rovera R, Porter JH, Mork A, Smagin G, Song D, Budac D, Cajina M, Sanchez C. Task- and treatment length-dependent effects of vortioxetine on scopolamine-induced cognitive dysfunction and hippocampal extracellular acetylcholine in rats. The Journal of Pharmacology and Experimental Therapeutics. PMID 27402279 DOI: 10.1124/Jpet.116.233924  0.777
2016 Prus AJ, Porter JH. The Discriminative Stimulus Properties of Drugs Used to Treat Depression and Anxiety. Current Topics in Behavioral Neurosciences. PMID 27352389 DOI: 10.1007/7854_2016_27  0.837
2016 Farrell MS, McCorvy JD, Huang XP, Urban DJ, White KL, Giguere PM, Doak AK, Bernstein AI, Stout KA, Park SM, Rodriguiz RM, Gray BW, Hyatt WS, Norwood AP, Webster KA, ... ... Porter JH, et al. In Vitro and In Vivo Characterization of the Alkaloid Nuciferine. Plos One. 11: e0150602. PMID 26963248 DOI: 10.1371/Journal.Pone.0150602  0.585
2015 Hillhouse TM, Merritt CR, Porter JH. Effects of the noncompetitive N-methyl-D-aspartate receptor antagonist ketamine on visual signal detection performance in rats. Behavioural Pharmacology. 26: 495-9. PMID 26154438 DOI: 10.1097/Fbp.0000000000000160  0.756
2015 Prus AJ, Mooney-Leber SM, Berquist MD, Pehrson AL, Porter NP, Porter JH. The antidepressant drugs fluoxetine and duloxetine produce anxiolytic-like effects in a schedule-induced polydipsia paradigm in rats: enhancement of fluoxetine's effects by the α2 adrenoceptor antagonist yohimbine. Behavioural Pharmacology. 26: 489-94. PMID 26154437 DOI: 10.1097/Fbp.0000000000000159  0.809
2015 Hillhouse TM, Porter JH. A brief history of the development of antidepressant drugs: from monoamines to glutamate. Experimental and Clinical Psychopharmacology. 23: 1-21. PMID 25643025 DOI: 10.1037/A0038550  0.713
2015 Pehrson A, Haddjeri N, Hillhouse T, Rovera R, Porter J, Mork A, Song D, Budac D, Smagin G, Sanchez C. P.2.a.006 Task- and treatment-dependent effects of vortioxetine on scopolamine-induced cognitive dysfunction and cortical extracellular acetylcholine European Neuropsychopharmacology. 25: S378. DOI: 10.1016/S0924-977X(15)30490-9  0.769
2014 Hillhouse TM, Porter JH, Negus SS. Comparison of antidepressant-like and abuse-related effects of phencyclidine in rats. Drug Development Research. 75: 479-88. PMID 25315690 DOI: 10.1002/Ddr.21228  0.785
2014 Donahue TJ, Hillhouse TM, Webster KA, Young R, De Oliveira EO, Porter JH. (S)-amisulpride as a discriminative stimulus in C57BL/6 mice and its comparison to the stimulus effects of typical and atypical antipsychotics. European Journal of Pharmacology. 734: 15-22. PMID 24726559 DOI: 10.1016/J.Ejphar.2014.03.047  0.862
2014 Hillhouse TM, Porter JH, Negus SS. Reply to: Rapid antidepressant effects and abuse liability of ketamine. Psychopharmacology. 231: 2043-4. PMID 24658446 DOI: 10.1007/S00213-014-3544-Z  0.73
2014 Hillhouse TM, Porter JH, Negus SS. Dissociable effects of the noncompetitive NMDA receptor antagonists ketamine and MK-801 on intracranial self-stimulation in rats. Psychopharmacology. 231: 2705-16. PMID 24522331 DOI: 10.1007/S00213-014-3451-3  0.716
2014 Hillhouse TM, Porter JH. Ketamine, but not MK-801, produces antidepressant-like effects in rats responding on a differential-reinforcement-of-low-rate operant schedule. Behavioural Pharmacology. 25: 80-91. PMID 24370559 DOI: 10.1097/Fbp.0000000000000014  0.755
2013 Hillhouse TM, Joseph BL, Steele FF, Negus SS, Porter JH. E.18 - IS KETAMINE AN ANESTHETIC, DRUG OF ABUSE, OR ANTIDEPRESSANT? Behavioural Pharmacology. 24: e46. DOI: 10.1097/01.Fbp.0000434837.31128.19  0.78
2013 Webster K, Hillhouse T, Donahue T, Friar M, Joseph B, Beardsley P, Windle J, Stewart J, Porter J. A.10 - EFFECTS OF D-AMPHETAMINE IN VESICULAR MONOAMINE TRANSPORTER (VMAT)1 KNOCKOUT MICE SUGGEST A SCHIZOPHRENIC PHENOTYPE IN CONDITIONED AND UNCONDITIONED BEHAVIOR Behavioural Pharmacology. 24: e25. DOI: 10.1097/01.Fbp.0000434771.21238.50  0.781
2013 Donahue TJ, Webster KA, Hillhouse TM, Friar MA, De Oliveria EO, Porter JH. A.4 - A COMPARISON OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF THE ATYPICAL ANTIPSYCHOTIC AMISULPRIDE AND THE TYPICAL ANTIPSYCHOTIC HALOPERIDOL IN C57BL/6 MICE Behavioural Pharmacology. 24: e23. DOI: 10.1097/01.Fbp.0000434765.90743.6C  0.815
2012 Wiebelhaus JM, Vunck SA, Meltzer HY, Porter JH. Discriminative stimulus properties of N-desmethylclozapine, the major active metabolite of the atypical antipsychotic clozapine, in C57BL/6 mice. Behavioural Pharmacology. 23: 262-70. PMID 22547022 DOI: 10.1097/Fbp.0B013E3283534332  0.857
2011 Wiebelhaus JM, Webster KA, Meltzer HY, Porter JH. The metabolites N-desmethylclozapine and N-desmethylolanzapine produce cross-tolerance to the discriminative stimulus of the atypical antipsychotic clozapine in C57BL/6 mice. Behavioural Pharmacology. 22: 458-67. PMID 21712711 DOI: 10.1097/Fbp.0B013E328348Ec4F  0.735
2011 Vunck SA, Wiebelhaus JM, Arnt J, Porter JH. Clozapine and N-methyl-D-aspartate have positive modulatory actions on their respective discriminative stimulus properties in C57BL/6 mice. European Journal of Pharmacology. 650: 579-85. PMID 20969851 DOI: 10.1016/J.Ejphar.2010.10.022  0.834
2009 Vann RE, Wise LE, Varvel SA, Philibin SD, Walentiny DM, Porter JH. Route of administration influences substitution patterns in rats trained to discriminate methadone vs. vehicle. Drug and Alcohol Dependence. 103: 124-30. PMID 19443130 DOI: 10.1016/J.Drugalcdep.2009.02.015  0.799
2009 Porter JH, Prus AJ. Drug discrimination: 30 years of progress. Psychopharmacology. 203: 189-91. PMID 19225764 DOI: 10.1007/S00213-009-1478-7  0.829
2009 Philibin SD, Walentiny DM, Vunck SA, Prus AJ, Meltzer HY, Porter JH. Further characterization of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in C57BL/6 mice: role of 5-HT(2A) serotonergic and alpha (1) adrenergic antagonism. Psychopharmacology. 203: 303-15. PMID 18989659 DOI: 10.1007/S00213-008-1385-3  0.814
2009 Porter JH, Prus AJ. Discriminative stimulus properties of atypical and typical antipsychotic drugs: a review of preclinical studies. Psychopharmacology. 203: 279-94. PMID 18795269 DOI: 10.1007/S00213-008-1308-3  0.867
2009 Prus AJ, Pehrson AL, Philibin SD, Wood JT, Vunck SA, Porter JH. The role of M1 muscarinic cholinergic receptors in the discriminative stimulus properties of N-desmethylclozapine and the atypical antipsychotic drug clozapine in rats. Psychopharmacology. 203: 295-301. PMID 18685832 DOI: 10.1007/S00213-008-1262-0  0.836
2008 Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE, Aprille JR, Dwyer DS, Li XM, Mahadik SP, Duman RS, Porter JH, Modica-Napolitano JS, Newton SS, Csernansky JG. Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacological Reviews. 60: 358-403. PMID 18922967 DOI: 10.1124/Pr.107.00107  0.337
2008 Porter JH, Walentiny DM, Philibin SD, Vunck SA, Crabbe JC. A comparison of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in DBA/2 and C57BL/6 inbred mice. Behavioural Pharmacology. 19: 530-42. PMID 18690107 DOI: 10.1097/Fbp.0B013E32830Cd84E  0.808
2006 Prus AJ, Philibin SD, Pehrson AL, Porter JH. Discriminative stimulus properties of the atypical antipsychotic drug clozapine in rats trained to discriminate 1.25 mg/kg clozapine vs. 5.0 mg/kg clozapine vs. vehicle. Behavioural Pharmacology. 17: 185-94. PMID 16495726 DOI: 10.1097/01.Fbp.0000197457.70774.91  0.858
2005 Prus AJ, Philibin SD, Pehrson AL, Porter JH. Generalization to atypical antipsychotic drugs depends on training dose in rats trained to discriminate 1.25 mg/kg clozapine versus 5.0 mg/kg clozapine versus vehicle in a three-choice drug discrimination task. Behavioural Pharmacology. 16: 511-20. PMID 16170228 DOI: 10.1097/01.fbp.0000172735.73876.06  0.832
2005 Philibin SD, Prus AJ, Pehrson AL, Porter JH. Serotonin receptor mechanisms mediate the discriminative stimulus properties of the atypical antipsychotic clozapine in C57BL/6 mice. Psychopharmacology. 180: 49-56. PMID 15696329 DOI: 10.1007/S00213-005-2147-0  0.853
2005 Porter JH, Prus AJ, Vann RE, Varvel SA. Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure in rats. Psychopharmacology. 178: 67-77. PMID 15316715 DOI: 10.1007/S00213-004-1985-5  0.86
2005 Prus A, Philibin S, Pehrson A, Wood E, Porter J. A82 THE DISCRIMINATIVE STIMULUS PROPERTIES OF THE ATYPICAL ANTIPSYCHOTIC DRUG CLOZAPINE IN RATS TRAINED TO DISCRIMINATE 1.25???mg/kg CLOZAPINE VERSUS 5.0???mg/kg CLOZAPINE VERSUS VEHICLE IN A THREE-CHOICE DRUG DISCRIMINATION TASK Behavioural Pharmacology. 16: S49. DOI: 10.1097/00008877-200509001-00155  0.845
2005 Porter J, Cooper R, Prus A, Stephens C, Pehrson A, Wood E, Porter N, Glowa J. A64 THE ??2 ANTAGONIST YOHIMBINE ACCELERATES THE EFFECTS OF THE SSRI FLUOXETINE ON SCHEDULE-INDUCED POLYDIPSIA Behavioural Pharmacology. 16: S43. DOI: 10.1097/00008877-200509001-00136  0.777
2005 Prus AJ, Philibin SD, Pehrson AL, Stephens CL, Cooper RN, Wise LE, Porter JH. Generalization testing with atypical and typical antipsychotic drugs in rats trained to discriminate 5.0 mg/kg clozapine from vehicle in a two-choice drug discrimination task Drug Development Research. 64: 55-65. DOI: 10.1002/Ddr.10419  0.834
2002 Varvel SA, Vann RE, Wise LE, Philibin SD, Porter JH. Effects of antipsychotic drugs on operant responding after acute and repeated administration. Psychopharmacology. 160: 182-91. PMID 11875636 DOI: 10.1007/s00213-001-0969-y  0.844
2000 Porter JH, Varvel SA, Vann RE, Philibin SD, Wise LE. Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in rats. Psychopharmacology. 149: 189-93. PMID 10805615 DOI: 10.1007/S002139900366  0.853
2000 Porter JH, McCallum SE, Varvel SA, Vann RE. The discriminative stimulus properties of the atypical antipsychotic olanzapine in rats. Psychopharmacology. 148: 224-33. PMID 10755735 DOI: 10.1007/S002130050046  0.79
1999 Porter JH, Covington HE, Varvel SA, Vann RE, Warren TA. Chlorpromazine as a discriminative stimulus in rats: Generalization to typical and atypical antipsychotics Drug Development Research. 48: 38-44. DOI: 10.1002/(Sici)1098-2299(199909)48:1<38::Aid-Ddr5>3.0.Co;2-C  0.793
1999 Porter JH, Villanueva HF, Rosecrans JA. Role of D1 and D2 dopamine receptors in the discriminative stimulus properties of the atypical antipsychotic clozapine in rats Drug Development Research. 46: 139-147. DOI: 10.1002/(SICI)1098-2299(199902)46:2<139::AID-DDR7>3.0.CO;2-S  0.54
1998 Wiley JL, Compton AD, Holcomb JD, McCallum SE, Varvel SA, Porter JH, Balster RL. Effects of modulation of NMDA neurotransmission on response rate and duration in a conflict procedure in rats. Neuropharmacology. 37: 1527-34. PMID 9886675 DOI: 10.1016/S0028-3908(98)00152-X  0.777
1997 Kelley BM, Porter JH. The role of muscarinic cholinergic receptors in the discriminative stimulus properties of clozapine in rats. Pharmacology, Biochemistry, and Behavior. 57: 707-19. PMID 9258998 DOI: 10.1016/S0091-3057(96)00342-5  0.41
1996 Porter JH, Strong SE. Discriminative stimulus control with olanzapine: generalization to the atypical antipsychotic clozapine. Psychopharmacology. 128: 216-9. PMID 8956383 DOI: 10.1007/s002130050127  0.556
1995 Kelley BM, Porter JH, Varvel SA. Mianserin as a discriminative stimulus in rats: asymmetrical cross-generalization with scopolamine. Psychopharmacology. 120: 491-3. PMID 8539332 DOI: 10.1007/Bf02245823  0.758
1994 Wiley JL, Compton AD, Porter JH. Differential effects of clozapine and pimozide on fixed-ratio responding during repeated dosing. Pharmacology, Biochemistry, and Behavior. 48: 253-7. PMID 8029297 DOI: 10.1016/0091-3057(94)90524-X  0.639
1994 Porter JH, Heath GF, Rosecrans JA. Antagonism of diazepam's anticonflict effects in rats by nicotine, but not by arecoline Drug Development Research. 31: 45-51. DOI: 10.1002/Ddr.430310108  0.372
1993 Villanueva HF, Porter JH. Differential tolerance to the behavioral effects of chronic pimozide and clozapine on multiple random interval responding in rats. Behavioural Pharmacology. 4: 201-208. PMID 11224187  0.446
1993 Wiley JL, Compton AD, Porter JH. Effects of four antipsychotics on punished responding in rats. Pharmacology, Biochemistry, and Behavior. 45: 263-7. PMID 8101005 DOI: 10.1016/0091-3057(93)90237-N  0.635
1993 Wiley JL, Porter JH. Effects of serotonergic drugs in rats trained to discriminate clozapine from haloperidol Bulletin of the Psychonomic Society. 31: 94-96. DOI: 10.3758/Bf03334149  0.726
1992 Wiley JL, Porter JH. Serotonergic drugs do not substitute for clozapine in clozapine-trained rats in a two-lever drug discrimination procedure. Pharmacology, Biochemistry, and Behavior. 43: 961-5. PMID 1448493 DOI: 10.1016/0091-3057(92)90433-G  0.674
1992 Wiley JL, Porter JH, Compton AD, Balster RL. Antipunishment effects of acute and repeated administration of phencyclidine and NPC 12626 in rats. Life Sciences. 50: 1519-28. PMID 1349714 DOI: 10.1016/0024-3205(92)90142-C  0.679
1990 Wiley JL, Porter JH. Differential effects of haloperidol and clozapine on the reinforcing efficacy of food reward in an alleyway reacquisition paradigm. Pharmacology, Biochemistry, and Behavior. 36: 569-73. PMID 2377657 DOI: 10.1016/0091-3057(90)90257-I  0.645
1989 Porter JH, Wiley JL, Balster RL. Effects of phencyclidine-like drugs on punished behavior in rats. The Journal of Pharmacology and Experimental Therapeutics. 248: 997-1002. PMID 2539469  0.67
1989 Wiley JL, Porter JH, Faw WR. Haloperidol blocks reacquisition of operant running during extinction following a single priming trial with food reward Bulletin of the Psychonomic Society. 27: 340-342. DOI: 10.3758/Bf03334621  0.578
1988 Porter JH, Villanueva HF. Assessment of pimozide's motor and hedonic effects on operant behavior in rats. Pharmacology, Biochemistry, and Behavior. 31: 779-86. PMID 3252268 DOI: 10.1016/0091-3057(88)90383-8  0.375
1988 O'Neal MF, Means LW, Porter JH, Rosecrans JA, Mokler DJ. Rats that acquire a THC discrimination more rapidly are more sensitive to THC and faster in reaching operant criteria. Pharmacology, Biochemistry, and Behavior. 29: 67-71. PMID 2832856 DOI: 10.1016/0091-3057(88)90275-4  0.459
1987 Kaempf GL, Porter JH. Differential effects of pimozide and clozapine on schedule-controlled and scheduled-induced behaviors after acute and chronic administration. The Journal of Pharmacology and Experimental Therapeutics. 243: 437-45. PMID 3681693  0.312
1985 DeNoble VJ, Mele PC, Porter JH. Intravenous self-administration of pentobarbital and ethanol in rats. Pharmacology, Biochemistry, and Behavior. 23: 759-63. PMID 4080762 DOI: 10.1016/0091-3057(85)90068-1  0.365
1985 Murphy EP, Porter JH, Heath GF. Suppression of schedule-induced drinking and food-reinforced bar pressing by tail-pinch is not reversed by naloxone. Behavioral and Neural Biology. 43: 86-99. PMID 3994626 DOI: 10.1016/S0163-1047(85)91524-9  0.363
1985 Lynch MR, Porter JH. Failure to block opiate effects of oral etonitazene with naltrexone during 24-h choice testing Bulletin of the Psychonomic Society. 23: 241-244. DOI: 10.3758/BF03329838  0.359
1984 Lynch MR, Porter JH, Rosecrans JA. Latent inhibition in the aversion to oral methadone. Pharmacology, Biochemistry, and Behavior. 20: 467-72. PMID 6709677 DOI: 10.1016/0091-3057(84)90287-9  0.382
1984 Porter JH, Goldsmith PA, McDonough JJ, Heath GF, Johnson DN. Differential effects of dopamine blockers on the acquisition of schedule-induced drinking and deprivation-induced drinking Physiological Psychology. 12: 302-306. DOI: 10.3758/BF03327203  0.377
1983 Bryant WE, Porter JH. A comparison of schedule-induced wheel running in rats, hamsters, gerbils, and guinea pigs Bulletin of the Psychonomic Society. 21: 311-314. DOI: 10.3758/BF03334719  0.306
1983 Mcdonough JJ, Porter JH. Schedule-induced and water-deprivation-induced drinking in rats: Effects of hypertonic saline challenges to homeostatic thirst mechanisms Bulletin of the Psychonomic Society. 21: 403-406. DOI: 10.3758/BF03329993  0.309
1981 Hamm RJ, Porter JH, Kaempf GL. Stimulus generalization of schedule-induced polydipsia. Journal of the Experimental Analysis of Behavior. 36: 93-9. PMID 16812235 DOI: 10.1901/Jeab.1981.36-93  0.341
1980 Porter JH, Hastings MT, Pagels JF. Schedule-induced polydipsia in the cotton rat (Sigmodon hispidus) Bulletin of the Psychonomic Society. 16: 15-18. DOI: 10.3758/BF03337081  0.306
1979 Fischer RB, Porter JH. Failure to demonstrate schedule-induced polydipsia in the degu (Octodon degus). Psychological Reports. 44: 1276. PMID 538157 DOI: 10.2466/pr0.1979.44.3c.1276  0.328
1978 Hamm RJ, Porter JH, Oster GD. Compound stimulus control of operant, but not adjunctive, behavior Bulletin of the Psychonomic Society. 12: 167-170. DOI: 10.3758/Bf03329660  0.324
1977 Allen JD, Porter JH. Sources of control over schedule-induced drinking produced by second-order schedules of reinforcement. Physiology & Behavior. 18: 853-63. PMID 905397 DOI: 10.1016/0031-9384(77)90194-9  0.481
1977 Porter JH, Allen JD. Food-motivated performance in rats with ventromedial hypothalamic lesions: effects of body weight, deprivation, and preoperative training. Behavioral Biology. 19: 238-54. PMID 849225 DOI: 10.1016/S0091-6773(77)91530-9  0.457
1977 Porter JH, Sozer NN, Moeschl TP. Schedule-induced polydipsia in the guinea pig. Physiology & Behavior. 19: 573-5. PMID 613352 DOI: 10.1016/0031-9384(77)90237-2  0.302
1977 Porter JH, Allen JD. Schedule-induced polydipsia contrast in the rat Animal Learning & Behavior. 5: 184-192. DOI: 10.3758/Bf03214076  0.517
1976 Roehrs T, Allen JD, Porter JH. Acquisition of schedule-induced polydipsia in rats with no prior drinking experience. Physiology & Behavior. 17: 1011-3. PMID 14677597 DOI: 10.1016/0031-9384(76)90023-8  0.513
1975 Allen JD, Porter JH, Arazie R. Schedule-induced drinking as a function of percentage reinforcement. Journal of the Experimental Analysis of Behavior. 23: 223-32. PMID 16811843 DOI: 10.1901/Jeab.1975.23-223  0.456
1975 Porter JH, Arazie R, Holbrook JW, Cheek MS, Allen JD. Effects of variable and fixed second-order schedules on schedule-induced polydipsia in the rat. Physiology & Behavior. 14: 143-9. PMID 1161820 DOI: 10.1016/0031-9384(75)90158-4  0.491
1975 Allen JD, Porter JH. Demonstration of behavioral contrast with adjunctive drinking Physiology and Behavior. 15: 511-515. DOI: 10.1016/S0031-9384(75)80025-4  0.411
1975 Allen JD, Porter JH, Arazie R. Schedule induced drinking as a function of percentage reinforcement Journal of the Experimental Analysis of Behavior. 23: 223-232.  0.418
1974 Porter JH, Allen JD, Arazie R. Reinforcement frequency and body weight as determinants of motivated performance in hypothalamic hyperphagic rats. Physiology & Behavior. 13: 627-32. PMID 4471678 DOI: 10.1016/0031-9384(74)90232-7  0.396
1972 Porter JH, Allen JD. Food-motivated performance as a function of weight loss in hypothalamic hyperphagic rats Psychonomic Science. 28: 285-288. DOI: 10.3758/Bf03328742  0.398
Show low-probability matches.